Stada Partners With Calliditas On Novel Budesonide Formulation
Deal Worth Over $100m Targets First European Approval For Orphan IgAN Treatment
• By David Wallace
Stada has partnered with Calliditas on its innovative budesonide formulation • Source: Alamy 
